tm logo
MEDEON BIODESIGN
Live/Registered
PARTIAL SECTION 8 & 15 ACCEPTED AND ACKNOWLEDGED

on 11 Sep 2023

Last Applicant/ Owned by

HouGang Street, 7F, 116

Taipei 11170

TW

R.O.C.

Serial Number

86593991 filed on 10th Apr 2015

Registration Number

5042132 registered on 13th Sep 2016

in the Principal Register

Correspondent Address

Michael T. Smith

Michael T. Smith

8110 Gatehouse Road, Suite 100 East

Falls Church, VA, 22042

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

MEDEON BIODESIGN

Medical research; scientific research and development; technical research in the field of minimally invasive surgery [ Medical apparatus and instruments for use in minimally invasive surgery procedures ]

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Medical research; scientific research and development; technical research in the field of minimally invasive surgery


First Use Date in General

12th Jan 2015

First Use Date in Commerce

12th Jan 2015

Class [010]
Medical Instrument Products


[ Medical apparatus and instruments for use in minimally invasive surgery procedures ]


First Use Date in General

12th Jan 2015

First Use Date in Commerce

12th Jan 2015

Mark Details


Serial Number

No 86593991

Mark Type

No Service Mark

Attorney Docket Number

No 4404-0116US1

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
11th Sep 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11th Sep 2023REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
11th Sep 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
13th Mar 2023TEAS SECTION 8 & 15 RECEIVED
13th Sep 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
19th Jan 2021TEAS CHANGE OF OWNER ADDRESS RECEIVED
19th Jan 2021TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
19th Jan 2021ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
19th Jan 2021TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
19th Jan 2021TEAS CHANGE OF CORRESPONDENCE RECEIVED